Breast Cancer During Pregnancy: Balancing Fetal Health with Oncology Care

Breast cancer during pregnancy is rare but presents a challenging situation for both the mother and her medical team. The dual concern of treating cancer while ensuring the health of the developing fetus requires a multidisciplinary approach, with oncologists, obstetricians, and pediatricians working closely together. Diagnosing breast cancer during pregnancy is complicated because breast tissue undergoes changes that can mask lumps or other symptoms. This can result in delayed diagnoses, making the cancer more advanced by the time it is detected.

 

Treatment must be carefully timed to minimize risks to the fetus. Surgery to remove the tumor is generally considered safe during all trimesters of pregnancy, and in many cases, it is the first step. Chemotherapy, on the other hand, is usually avoided during the first trimester, as it could harm the developing baby. However, it may be administered during the second and third trimesters when the risk is lower. Radiation therapy and certain targeted therapies are typically postponed until after delivery due to the potential risks to the fetus.

 

ECCT provides a relatively safe and non-invasive cancer treatment during pregnancy, and most importantly does not harm to the fetus.

 

The emotional and psychological toll on pregnant women facing cancer treatment is immense. Many mothers struggle with feelings of guilt or fear about the potential impact on their baby. Having a robust support system, including mental health professionals, can be critical in helping women navigate this difficult experience. Post-treatment, breastfeeding may also be affected depending on the surgery and treatments undergone, so new mothers often need specialized advice.

 

Managing breast cancer during pregnancy requires a delicate balance, and ongoing research aims to improve treatment protocols to optimize outcomes for both mother and baby.